Intensified photodynamic therapy of actinic keratoses with fractional CO 2 laser: A randomized clinical trial

British Journal of Dermatology

Volumn 166, Issue 6, 2012, Pages 1262-1269

  Togsverd Bo, K ^a   Haak, C S ^a   Thaysen Petersen, D ^a   Wulf, H C ^a   Anderson, R R ^b   Haedesdal M ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; PROTOPORPHYRIN;

ABLATIVE FRACTIONAL LASER RESURFACING ASSISTED PHOTODYNAMIC THERAPY; ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CARBON DIOXIDE LASER; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHEMA; FEMALE; FLUORESCENCE IMAGING; FOLLOW UP; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; LIGHT EMITTING DIODE; LIGHT INTENSITY; LOW LEVEL LASER THERAPY; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT SAFETY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RED LIGHT; SKIN INJURY; SKIN PAIN; SKIN SCAR;

AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; HUMANS; KERATOSIS, ACTINIC; LASER THERAPY; LASERS, GAS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN AGING; TREATMENT OUTCOME;

EID: 84861566736     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10893.x     Document Type: Article

References (31)

1. Memon AA, Tomenson JA, Bothwell J, Friedmann PS,. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000; 142: 1154-9.
2. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 2007; 56: 125-43.
3. Morton CA, McKenna KE, Rhodes LE,. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008; 159: 1245-66.
4. Kennedy JC, Pottier RH, Pross DC,. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1992; 14: 275-92.
5. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002; 47: 258-62.
6. Tarstedt M, Rosdahl I, Berne B, et al. A randomized multicenter study to compare two treatment regimes of topical methyl aminolevulinate (Metvix®) PDT in actinic keratosis of the face and scalp. Acta Derm Venereol (Stockh) 2005; 85: 424-8.
7. Duncan KO, Geisse JK, Leffell DJ,. Epithelial precancerous lesions. In: Fitzpatrick's Dermatology in General Medicine (, Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds), 6th edn. New York: McGraw-Hill, 2003; 1007-15.
8. Smits T, Robles CA, van Erp PE, et al. Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid. J Invest Dermatol 2005; 125: 833-9.
9. Gerritsen MJP, Smits T, Kleinpenning MM, et al. Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology 2009; 218: 193-202.
10. Manstein D, Herron GS, Sink RK, et al. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34: 426-38.
11. 2 laser-assisted drug delivery. Lasers Surg Med 2010; 42: 113-22.
12. 2 laser pretreatment. Lasers Surg Med 2011; 43: 804-13.
13. Robinson DJ, de Bruijn HS, van der Veen N, et al. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol 1998; 67: 140-9.
14. Fritsch C, Homey B, Stahl W, et al. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic methylester. Photochem Photobiol 1998; 68: 218-21.
15. Olsen EA, Abernethy ML, Kulp-Shorten C, et al. A double blind, vehicle controlled study evaluating masoprocol cream in the treatment of actinic keratoses of the head and neck. J Am Acad Dermatol 1991; 24: 738-43.
16. Wiegell SR, Haedersdal M, Philipsen PA, et al. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol 2008; 158: 740-6.
17. Morton C, Campbell S, Gupta G, et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006; 155: 1029-36.
18. Wiegell SR, Hædersdal M, Eriksen P, Wulf HC,. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial. Br J Dermatol 2009; 160: 1308-14.
19. Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate (Metvix®) is effective and safe in the treatment of actinic keratosis: results of a prospective randomized trial. J Am Acad Dermatol 2003; 48: 227-32.
20. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective randomized study. J Dermatolog Treat 2003; 14: 99-106.
21. Friedman PM, Landau JM, Moody MN, et al. 1550 nm and 1927 nm fractional laser resurfacing for the treatment of actinic keratosis and photodamage: a comparative study. Presented at: American Society for Laser Medicine and Surgery Annual Conference, March 30-April 3, 2011, Grapevine, TX, U.S.A., abstract 64.
22. Weiss E, Anolik R, Brightman L, et al. Long-term follow-up of 1927 nm fractional resurfacing for actinic keratoses of the face. Presented at: American Society for Laser Medicine and Surgery Annual Conference, March 30-April 3, 2011, Grapevine, TX, U.S.A., abstract 65.
23. Yoo KH, Kim BJ, Kim MN,. Enhanced efficacy of photodynamic therapy with methyl 5-aminolevulinic acid in recalcitrant periungual warts after ablative carbon dioxide fractional laser: a pilot study. Dermatol Surg 2009; 35: 1927-32.
24. Togsverd-Bo K, Paasch U, Haak CS, Hædersdal M,. Lesion dimensions of ablative fractional laser in non-melanoma skin cancer and premalignant lesions. Lasers Med Sci 2012; 27: 675-9.
25. Forster B, Klein A, Szeimies R-M, Maisch T,. Penetration enhancement of two topical 5-aminolevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation. Exp Dermatol 2010; 19: 806-12.
26. Clementoni MT, B-Roscher M, Munavalli GS,. Photodynamic photorejuvenation of the face with a combination of microneedling, red light and broadband pulsed light. Lasers Surg Med 2010; 42: 150-9.
27. Ruiz-Rodriguez R, López L, Candelas D, Zelickson B,. Enhanced efficacy of photodynamic therapy after fractional resurfacing: fractional photodynamic rejuvenation. J Drugs Dermatol 2007; 6: 818-20.
28. Tyrrell JS, Morton C, Campbell SM, Curnow A,. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites. Br J Dermatol 2011; 164: 1362-8.
29. Wiegell SR, Skiveren J, Phillipsen PA, Wulf HC,. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 2008; 158: 727-33.
30. Sanclemente G, Medina L, Villa JF, et al. A prospective split-face double-blind randomized placebo-controlled trial to assess the efficacy of methyl aminolevulinate + red light in patients with facial photodamage. J Eur Acad Dermatol Venereol 2011; 25: 49-58.
31. 2 laser skin rejuvenation. Dermatol Ther 2011; 24: 41-53.